This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Europe's premier partnering event
November 4–6, 2024 | Stockholm, SwedenNovember 12–13, 2024 | Digital Partnering

Elpiscience Biopharma


Elpiscience is a clinical-stage biopharmaceutical company dedicated to developing life-changing immune-oncology therapies for cancer patients worldwide. Led by a team of enthusiastic scientists, the company has focused its pipeline on removing immunosuppressive factors in the tumor microenvironment, especially by targeting adenosine pathway and myeloid checkpoints. Elpiscience developed several novel molecules with its powerful Bispecific Macrophage Engager (BiME®) that connects and activates macrophages for solid tumor killing without causing cytokine storms.